Colgate-Palmolive (NYSE:CL) COO Panagiotis Tsourapas Sells 15,000 Shares

Colgate-Palmolive Company (NYSE:CL) COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Panagiotis Tsourapas also recently made the following trade(s):

• On Wednesday, February 11th, Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock. The stock was sold at an average price of $94.61, for a total value of $3,311,350.00.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $96.61 on Friday. The company has a market capitalization of $77.87 billion, a P/E ratio of 36.87, a PEG ratio of 4.34 and a beta of 0.29. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. The stock has a 50 day moving average price of $83.80 and a two-hundred day moving average price of $81.90.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the previous year, the firm earned $0.91 earnings per share. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. Analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Institutional Trading of Colgate-Palmolive

Institutional investors have recently added to or reduced their stakes in the business. Westside Investment Management Inc. raised its stake in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares during the last quarter. CBIZ Investment Advisory Services LLC increased its holdings in Colgate-Palmolive by 86.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after buying an additional 150 shares in the last quarter. Triumph Capital Management raised its position in Colgate-Palmolive by 62.9% in the 4th quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after buying an additional 127 shares during the last quarter. Vermillion & White Wealth Management Group LLC lifted its stake in Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after acquiring an additional 155 shares during the period. Finally, Jessup Wealth Management Inc purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $26,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. TD Cowen restated a “buy” rating on shares of Colgate-Palmolive in a report on Monday, February 2nd. Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. UBS Group raised their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Raymond James Financial cut their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Finally, Wells Fargo & Company upped their target price on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a report on Sunday, February 1st. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $94.38.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.